XIAOMI-W
01810
POP MART
09992
BABA-W
09988
4
MEITUAN-W
03690
5
HORIZONROBOT-W
09660
HK Stock MarketDetailed Quotes
03681 SINOMAB BIO-B
- 1.550
- -0.010-0.64%
Noon Break Apr 30 11:59 CST
1.69BMarket Cap-8.47P/E (TTM)
1.620High1.540Low586.20KVolume1.560Open1.560Pre Close931.48KTurnover0.05%Turnover RatioLossP/E (Static)1.09BShares1.93052wk High8.12P/B1.69BFloat Cap0.80052wk Low--Dividend TTM1.09BShs Float7.300Historical High--Dividend LFY5.13%Amplitude0.800Historical Low1.589Avg Price300Lot Size--Div YieldTTM--Div Yield LFY
SINOMAB BIO-B Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 48.42%2.03M | 48.42%2.03M | --1.37M | --1.37M | ---- | ---- | --25.91M | ---- | ---- | ---- |
| Operating income | 48.42%2.03M | 48.42%2.03M | 1.37M | 1.37M | 25.91M | |||||
| Cost of sales | -57.26%-1.48M | -57.26%-1.48M | ---943K | ---943K | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating expenses | -57.26%-1.48M | -57.26%-1.48M | -943K | -943K | ||||||
| Gross profit | 28.67%543K | 28.67%543K | 422K | 422K | ||||||
| Administrative expenses | 30.63%-67.72M | 31.86%-34.21M | -18.19%-97.62M | -48.31%-50.2M | 38.09%-82.59M | -3.01%-33.85M | -85.25%-133.4M | 34.32%-32.86M | -17.01%-72.01M | ---50.03M |
| Research and development expenses | 30.02%-94.75M | 17.55%-55.04M | 24.93%-135.41M | 18.73%-66.75M | 9.41%-180.37M | 8.73%-82.13M | -92.56%-199.11M | -88.18%-89.98M | 51.76%-103.4M | ---47.82M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | 14.37%-2.14M | -140.94%-5.82M | -63.98%-2.5M | -3.34%-2.42M | ---1.52M |
| Special items of operating profit | -270.80%-14.55M | 109.48%1.36M | 63.79%-3.93M | 36.09%-14.37M | -138.02%-10.84M | -278.31%-22.48M | -49.06%28.52M | -31.96%12.61M | 2,782.34%55.98M | --18.53M |
| Operating profit | 25.39%-176.48M | 33.28%-87.34M | 13.61%-236.53M | 6.90%-130.89M | 3.56%-273.8M | -24.72%-140.6M | -132.99%-283.91M | -39.45%-112.74M | 55.90%-121.85M | -80.84M |
| Financing cost | -31.55%-8.66M | -2.65%-3.29M | -32.69%-6.58M | ---3.2M | ---4.96M | ---- | ---- | ---- | ---- | ---- |
| Share of profits of associates | ---- | ---- | ---- | ---- | -25.81%-5.4M | -91.31%-3.19M | -474.16%-4.29M | ---1.67M | ---747K | ---- |
| Earning before tax | 23.85%-185.14M | 32.42%-90.62M | 14.45%-243.11M | 6.74%-134.1M | 1.40%-284.16M | -25.69%-143.79M | -135.07%-288.19M | -41.52%-114.4M | 55.63%-122.6M | -80.84M |
| After-tax profit from continuing operations | 23.85%-185.14M | 32.42%-90.62M | 14.45%-243.11M | 6.74%-134.1M | 1.40%-284.16M | -25.69%-143.79M | -135.07%-288.19M | -41.52%-114.4M | 55.63%-122.6M | -80.84M |
| Earning after tax | 23.85%-185.14M | 32.42%-90.62M | 14.45%-243.11M | 6.74%-134.1M | 1.40%-284.16M | -25.69%-143.79M | -135.07%-288.19M | -41.52%-114.4M | 55.63%-122.6M | -80.84M |
| Profit attributable to shareholders | 23.85%-185.14M | 32.42%-90.62M | 14.45%-243.11M | 6.74%-134.1M | 1.40%-284.16M | -25.69%-143.79M | -135.07%-288.19M | -41.52%-114.4M | 55.63%-122.6M | -80.84M |
| Basic earnings per share | 29.17%-0.17 | 38.46%-0.08 | 17.24%-0.24 | 13.33%-0.13 | 0.00%-0.29 | -36.36%-0.15 | -141.67%-0.29 | -37.50%-0.11 | 63.64%-0.12 | -0.08 |
| Diluted earnings per share | 29.17%-0.17 | 38.46%-0.08 | 17.24%-0.24 | 13.33%-0.13 | 0.00%-0.29 | -36.36%-0.15 | -141.67%-0.29 | -37.50%-0.11 | 63.64%-0.12 | -0.08 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.